Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Current Liabilities -----

What is the latest Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is - based on Mar2025 Consolidated results.
Year Current Liabilities
Mar2025-
Mar2024-
Mar2023-
Mar2022-
Mar2017-

How is Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Current Liabilities % Change
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2017 - -

Compare Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,183.5 Cr 6.8% -13% -34.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹381,326.0 Cr -0.2% -6.3% -8.8% Stock Analytics
DIVIS LABORATORIES ₹160,299.0 Cr 3.3% -3.4% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,821.0 Cr -0.7% 3.8% 26.3% Stock Analytics
CIPLA ₹106,655.0 Cr -3% -11.8% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,861.0 Cr 6% -3.5% -4.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

6.8%

-13%

-34.6%

SENSEX

0.8%

-2.9%

8.1%


You may also like the below Video Courses